Materials and methods for controlling infections
OwnerPaul J. RUCINSKIinventor
Life of this patent
Estimating the term…
Abstract
The subject invention provides materials and methods for reducing ocular infections in subjects. The materials and methods utilize chlorhexidine, which has been found to be unexpectedly non-toxic to humans and other animals in low concentrations. The lack of toxicity facilitates the use of chlorhexidine in contexts that were not previously thought possible.
Claims13
A method for treating a subject at risk of or having inflammation or infection at an ocular site, wherein said method comprises administering to the ocular site of the subject a formulation that comprises chlorhexidine at a concentration of 1% or less.
A kit comprising a first container containing a composition that comprises chlorhexidine at a concentration of 1% or less and a second container containing an aqueous albumin or Ringer's solution, wherein the kit comprises at least one dispensing nozzle.
A method for treating a subject at risk of or having inflammation or infection at an ocular site, wherein said method comprises administering to the ocular site of the subject a first formulation, wherein the first formulation is an aqueous albumin solution or a protein-free agent solution suitable for ocular administration and administering a second formulation that comprises chlorhexidine at a concentration of 1% or less.
Dependencies are inferred from the claim text.